This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First?

CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing ...

US stocks rise as Nvidia reports third-quarter earnings

Nvidia reported its third quarter earnings after the bell in New York on Wednesday, beating analysts' estimates on the top ...